Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Non-Resectable Adult Liver Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00639509
What this trial is testing

IMC-A12 in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)WithdrawnNCT01194206
What this trial is testing

Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00006016
What this trial is testing

Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer
National Cancer Institute (NCI) 75
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Testing effectiveness (Phase 2)Active Not RecruitingNCT03680508
What this trial is testing

TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer

Who this might be right for
Adult Primary Liver CancerAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer
University of Hawaii 42
Large-scale testing (Phase 3)Study completedNCT03239158
What this trial is testing

Bioinformation Therapy for Liver Cancer

Who this might be right for
Liver, Cancer of, Non-Resectable
Fuda Cancer Hospital, Guangzhou 120
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Testing effectiveness (Phase 2)Study completedNCT00949182
What this trial is testing

Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Rutgers, The State University of New Jersey 20
Testing effectiveness (Phase 2)Study completedNCT01624285
What this trial is testing

Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaLocalized Resectable Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
Jonsson Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)WithdrawnNCT01859182
What this trial is testing

Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the GallbladderAdult Primary Cholangiocellular Carcinoma+12 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT00293397
What this trial is testing

Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
Yale University 20
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Not applicableUnknownNCT05103007
What this trial is testing

PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Tongji Hospital 200
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Early research (Phase 1)UnknownNCT06463444
What this trial is testing

Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models

Who this might be right for
HCCPrecision Therapy
Chen Xiaoping 30
Not applicableStudy completedNCT00607828
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
University of Nebraska 7
Testing effectiveness (Phase 2)UnknownNCT00276705
What this trial is testing

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

Who this might be right for
Liver Cancer
Children's Cancer and Leukaemia Group 47
Next Page